News on Medial

Lifetime Health raises $1.5 Mn in seed round

EntrackrEntrackr · 11m ago
Lifetime Health raises $1.5 Mn in seed round
Medial

Lifetime Health, a digital platform for at-home care, has secured $1.5 million in a seed round led by US-based venture capital firm The Garage Syndicate along with participation from other angel investors. The company had previously raised $900,000 in its last round from an existing investor. The fresh proceeds will be deployed towards further development, Lifetime Health said in a press release. Co-founded in 2023 by Konstantin Riabtsev, Michail Vorobiev and Nabil Ahmed, Lifetime Health is a digital platform for hospital-at-home care providing phlebotomy services, diagnostic tools, medical devices, nursing care, physiotherapy, and postoperative care all in one app. Its automated platform ensures fast, high-quality, and affordable service, from the client’s order to the nurse’s departure and results processing. Lifetime Health is currently operating in Bengaluru and its partner network includes 200 local clinics. It aims to reach major Indian cities and connect over 10,000 medical offices nationwide. intends to enable medical service orders at home for residents across Bangalore and its suburbs, and expand to Mumbai. The platform expects to have 1,000 doctors registered on the platform, with at least 300 of them becoming active users who can schedule appointments online, make appointments and recommendations, and maintain patient histories in digital format. The other startups in this space are Caresathome, CASAMED, Muse Diagnostic, Care24-India, and others.

Related News

Deeptech startup Acculi Labs raises $1.5 Mn

EntrackrEntrackr · 11m ago
Deeptech startup Acculi Labs raises $1.5 Mn
Medial

Acculi Labs, a deep-tech life growth solution provider, has raised $1.5 million in a new investment round at a valuation of $25 million led by Sabi Holding India Ltd. The Bengaluru-based company had earlier raised Rs 5 crore in a seed funding round led by PirE Ventures back in 2020. The fresh fund will be utilized to accelerate the development of its conscious AI insights systems, enhance its manpower, operational efficiency, infrastructure development, Acculi Labs said in a press-release. Co-founded in May 2017 by Rupam Das and Hari Prasath M, Acculi Labs aims to make home-based care available to the patients. The company’s flagship product, Lyfas, enables easy and regular early diagnostics and monitoring for early-stage asymptomatic patients and helps them to approach their doctor at an early stage. According to Acculi Labs, it expanded offerings from an initial cardiac health assessment system to a comprehensive suite of health solutions with the launch of Lyfas.The platform claims that its mobile application is capable of non-invasively capturing psychophysiological biomarkers and delivering a detailed health report within three minutes. The company has developed Lyra, a cutting-edge, conscious AI that bridges the gap between carbon and silicon life forms. It has also launched Lyfas Udyam initiative, which provides a micro entrepreneurial circular economy for small entrepreneurs to start and run their businesses, leveraging the ecosystem, processes, and finance.

Darwix AI raises $1.5 Mn in seed funding round

EntrackrEntrackr · 18d ago
Darwix AI raises $1.5 Mn in seed funding round
Medial

Darwix AI raises $1.5 Mn in seed funding round Darwix AI, an omnichannel generative AI platform for enterprise sales and service conversations, has raised $1.5 million in a seed funding round from Rebalance, IPV, JITO Incubation and Innovation Foundation, Growth Sense, and Growth91, along with participation from angel investors such as Ankit Nagori, Sanjay Suri, Amit Lakhotia, and Mekin Maheshwari. The fresh capital will be used for product development and market expansion, the company said in a press release. Co-founded in 2022 by Ajay Sethi, Hanit Awal, and Kushal Das, Darwix AI has built a first-of-its-kind, deeply integrated omnichannel generative AI stack that provides conversational intelligence, assistance, and automation for enterprise sales. Its all-in-one platform is designed to give organizations complete visibility into customer interactions and enhance each customer touchpoint. According to the company, its generative AI stack powers omnichannel interactions for large enterprises in banking, financial services, insurance, and retail sectors, with a presence across leading players in the United States, India, and the Middle East. Built on a proprietary multi-tenant large language model infrastructure with advanced software and hardware integrations, the solution is tailored to empower these industries. “Our goal is to offer a unified generative AI stack that not only understands but also elevates every customer interaction with actionable intelligence and automation. This fundraise gives us the fuel to double down on product innovation and expand our presence in the United States,” said Ajay Sethi, Co-founder of Darwix AI. The company’s Transform Plus platform delivers real-time conversational intelligence, agent assistance, and automation across voice, chat, email, and in-person channels through its multi-tenant infrastructure.

Visit Health raises $30 Mn in primary and secondary transaction

EntrackrEntrackr · 11m ago
Visit Health raises $30 Mn in primary and secondary transaction
Medial

Telehealth and wellness platform Visit Health has raised Rs 250 crore ($30 million) in a combination of primary and secondary purchase of stake in the company held by Docprime Technologies, the current promoters and employees. Visit Health will use the funds to expand its business which involves a strategic partnership with health and wellness platform TatvaCare, the company said in a press release. In October 2021, DocPrime invested around $7.5 million in Visit Health. The New Delhi-based company had also scooped up $1.4 million in seed round from investors such as MapmyIndia, Snapdeal co-founders Kunal Bahl and Rohit Bansal, and Hetero Drugs Director Murali Krishna. In May, PB Fintech said that it will divest 29% of its holdings in Visit Health, which will be valued at Rs 76 crore ($9 million). The firm also added that it will make a divestment of Rs 2 crore in Visit Internet. Eight-year-old Visit Health offers customized wellness & OPD programs for SMEs and corporates’ employees and their families. It claims to serve more than 400 companies through its network of hospitals. Startup data intelligence platform TheKredible shows that DocPrime controlled 14.4% stake in Visit Health as of Series A round. For the fiscal year ending in March 2023 (FY23), Visit Health registered nearly three-fold jump in its revenue to Rs 53 crore from Rs 17.55 crore in FY22. The company managed to keep its losses below Rs 1 crore in FY23. It is yet to file FY24 numbers. On Tuesday, PB Fintech released its quarterly results. The company’s revenue slipped to Rs 1,010 crore in Q1 FY25 as compared to Rs 1,090 crore during the quarter ended March 2024. Despite the decline in scale, it managed to maintain steady profits, which stood at Rs 60 crore in Q1 FY25. Update: The headline and story have been updated to add correct information from Visit Health’s press release.

Download the medial app to read full posts, comements and news.